- Home
- JLL vs CHWY Comparison
JLL vs CHWY Comparison
Compare JLL & CHWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JLL
- CHWY
- Stock Information
- Founded
- JLL 1997
- CHWY 2010
- Country
- JLL United States
- CHWY United States
- Employees
- JLL N/A
- CHWY N/A
- Industry
- JLL Real Estate
- CHWY Catalog/Specialty Distribution
- Sector
- JLL Finance
- CHWY Consumer Discretionary
- Exchange
- JLL Nasdaq
- CHWY Nasdaq
- Market Cap
- JLL 14.1B
- CHWY 16.5B
- IPO Year
- JLL 1997
- CHWY 2019
- Fundamental
- Price
- JLL $286.30
- CHWY $37.56
- Analyst Decision
- JLL Buy
- CHWY Strong Buy
- Analyst Count
- JLL 8
- CHWY 25
- Target Price
- JLL $328.57
- CHWY $45.17
- AVG Volume (30 Days)
- JLL 364.5K
- CHWY 9.6M
- Earning Date
- JLL 11-05-2025
- CHWY 09-10-2025
- Dividend Yield
- JLL N/A
- CHWY N/A
- EPS Growth
- JLL 47.74
- CHWY N/A
- EPS
- JLL 11.64
- CHWY 0.35
- Revenue
- JLL $24,676,200,000.00
- CHWY $12,345,235,000.00
- Revenue This Year
- JLL $11.87
- CHWY $8.77
- Revenue Next Year
- JLL $8.59
- CHWY $7.09
- P/E Ratio
- JLL $24.64
- CHWY $107.70
- Revenue Growth
- JLL 13.47
- CHWY 9.17
- 52 Week Low
- JLL $194.36
- CHWY $26.28
- 52 Week High
- JLL $322.37
- CHWY $48.62
- Technical
- Relative Strength Index (RSI)
- JLL 32.50
- CHWY 44.91
- Support Level
- JLL $291.45
- CHWY $36.93
- Resistance Level
- JLL $304.75
- CHWY $40.55
- Average True Range (ATR)
- JLL 5.93
- CHWY 1.29
- MACD
- JLL -3.27
- CHWY -0.08
- Stochastic Oscillator
- JLL 0.31
- CHWY 19.65
About JLL Jones Lang LaSalle Incorporated
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $74 billion for clients across diverse public and private real estate strategies.
About CHWY Chewy Inc.
Chewy is the largest e-commerce petcare retailer in the US, generating $11.9 billion in fiscal 2024 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods like crates, leashes, and bowls.